NBP250412G
Respiratory Syncytial Virus Glycoprotein F Antibody (11-2-F3), DyLight 488, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP250412G-Each-of-1 | In Stock | ₹ 47,956.38 |
NBP250412G - Each of 1
In Stock
Quantity
1
Base Price: ₹ 47,956.38
GST (18%): ₹ 8,632.148
Total Price: ₹ 56,588.528
Antigen
Respiratory Syncytial Virus Glycoprotein F
Classification
Monoclonal
Conjugate
DyLight 488
Formulation
50mM Sodium Borate with 0.05% Sodium Azide
Immunogen
Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity
0.1 mL
Research Discipline
Virology Bacteria and Parasites
Test Specificity
This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage
Store at 4C in the dark.
Isotype
IgG1
Applications
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone
11-2-F3
Dilution
Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species
Mouse
Purification Method
Protein A purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Virus
Form
Purified
Related Products
Description
- Respiratory Syncytial Virus Glycoprotein F Monoclonal specifically detects Respiratory Syncytial Virus Glycoprotein F in Virus samples
- It is validated for Western Blot, ELISA, Immunocytochemistry/Immunofluorescence.
Compare Similar Items
Show Difference
Antigen: Respiratory Syncytial Virus Glycoprotein F
Classification: Monoclonal
Conjugate: DyLight 488
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Immunogen: Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity: 0.1 mL
Research Discipline: Virology Bacteria and Parasites
Test Specificity: This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage: Store at 4C in the dark.
Isotype: IgG1
Applications: Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone: 11-2-F3
Dilution: Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species: Mouse
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Virus
Form: Purified
Antigen:
Respiratory Syncytial Virus Glycoprotein F
Classification:
Monoclonal
Conjugate:
DyLight 488
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Immunogen:
Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity:
0.1 mL
Research Discipline:
Virology Bacteria and Parasites
Test Specificity:
This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage:
Store at 4C in the dark.
Isotype:
IgG1
Applications:
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone:
11-2-F3
Dilution:
Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species:
Mouse
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Virus
Form:
Purified
Antigen: Respiratory Syncytial Virus Glycoprotein F
Classification: Monoclonal
Conjugate: DyLight 755
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Immunogen: Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity: 0.1 mL
Research Discipline: Virology Bacteria and Parasites
Test Specificity: This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage: Store at 4C in the dark.
Isotype: IgG1
Applications: Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone: 11-2-F3
Dilution: Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species: Mouse
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Virus
Form: Purified
Antigen:
Respiratory Syncytial Virus Glycoprotein F
Classification:
Monoclonal
Conjugate:
DyLight 755
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Immunogen:
Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity:
0.1 mL
Research Discipline:
Virology Bacteria and Parasites
Test Specificity:
This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage:
Store at 4C in the dark.
Isotype:
IgG1
Applications:
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone:
11-2-F3
Dilution:
Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species:
Mouse
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Virus
Form:
Purified
Antigen: Respiratory Syncytial Virus Glycoprotein F
Classification: Monoclonal
Conjugate: DyLight 350
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Immunogen: Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity: 0.1 mL
Research Discipline: Virology Bacteria and Parasites
Test Specificity: This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage: Store at 4C in the dark.
Isotype: IgG1
Applications: Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone: 11-2-F3
Dilution: Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species: Mouse
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Virus
Form: Purified
Antigen:
Respiratory Syncytial Virus Glycoprotein F
Classification:
Monoclonal
Conjugate:
DyLight 350
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Immunogen:
Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity:
0.1 mL
Research Discipline:
Virology Bacteria and Parasites
Test Specificity:
This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage:
Store at 4C in the dark.
Isotype:
IgG1
Applications:
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone:
11-2-F3
Dilution:
Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species:
Mouse
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Virus
Form:
Purified
Antigen: Respiratory Syncytial Virus Glycoprotein F
Classification: Monoclonal
Conjugate: DyLight 405
Formulation: 50mM Sodium Borate with 0.05% Sodium Azide
Immunogen: Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity: 0.1 mL
Research Discipline: Virology Bacteria and Parasites
Test Specificity: This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage: Store at 4C in the dark.
Isotype: IgG1
Applications: Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone: 11-2-F3
Dilution: Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species: Mouse
Purification Method: Protein A purified
Regulatory Status: RUO
Primary or Secondary: Primary
Target Species: Virus
Form: Purified
Antigen:
Respiratory Syncytial Virus Glycoprotein F
Classification:
Monoclonal
Conjugate:
DyLight 405
Formulation:
50mM Sodium Borate with 0.05% Sodium Azide
Immunogen:
Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C
Quantity:
0.1 mL
Research Discipline:
Virology Bacteria and Parasites
Test Specificity:
This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, wi
Content And Storage:
Store at 4C in the dark.
Isotype:
IgG1
Applications:
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Clone:
11-2-F3
Dilution:
Western Blot, ELISA, Immunocytochemistry/Immunofluorescence
Host Species:
Mouse
Purification Method:
Protein A purified
Regulatory Status:
RUO
Primary or Secondary:
Primary
Target Species:
Virus
Form:
Purified